anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Title

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 303,780
Current window 237,421-237,450
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all
18 30 60

Component

237,421-237,450 of 303,780

filter-aware
22
Hilltop Holdings | Results Presentation Deck | 22 slidesHilltop Holdings | Results Presentation Deck | 22 slides · Hilltop Holdings
Conference presentation Investor relations Beat · Business Segments1 hit
01
Slide 1
MindMed | Investor Presentation Deck | 28 slidesMindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
02
MindMed | Investor Presentation Deck | 28 slidesMindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
04
The slide uses a timeline framework to map clinical trial progress against calendar periods.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
05
The chart uses a Gantt-style visualization to represent clinical trial progress.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
06
The slide uses a combination of clinical data points and qualitative stakeholder feedback to establish the problem.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
Uses a 'Before-After' framing structure.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
Data compares all psychiatric providers vs interventional psychiatric providers across two survey questions.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
MindMed | Investor Presentation Deck | 28 slidesMindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
10
Uses a process flow diagram to illustrate the biological mechanism from receptor activation to clinical outcome.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
11
The slide uses a visual metaphor of a cluttered, anxious mind alongside a list of clinical and economic impacts.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations Beat · Agitate1 hit
12
Includes a large callout for the primary prevalence statistic and a list of clinical/economic impacts.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations Beat · Agitate1 hit
13
The slide outlines a multi-arm clinical development strategy with standardized trial designs (Part A/B) across different indications.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
14
Includes clinical trial data references and definitions for CGI-S and HAM-A.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations Beat · Evidence & Proof1 hit
15
The slide presents two line charts comparing MM120 (100 µg) against placebo across two primary clinical endpoints.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations Beat · Evidence & Proof1 hit
16
The slide uses a line chart to show longitudinal symptom reduction and a bar chart to show categorical outcomes (responders/remitters).MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations Beat · Evidence & Proof1 hit
17
The slide uses a structured layout with three distinct categories of safety findings (tolerability, SAEs, suicidality).MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
18
The slide outlines a two-part study design (Part A: Randomized/Double-Blind, Part B: Open-Label Extension) with specific patient counts and dosing regimens.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
19
The slide outlines two study arms (MM120 ODT 100 µg and Placebo) with a primary endpoint at week 6, followed by a 40-week extension.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
20
The slide uses a linked-circle diagram to represent a sequence or interconnected set of regulatory requirements.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
21
MindMed | Investor Presentation Deck | 28 slidesMindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
22
The central diagram is a circular hub-and-spoke model representing the MM120 Value Proposition.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
23
The 'Quadruple Aim' is a well-known healthcare framework. The visual is a quadrant diagram.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
24
The slide highlights the existing infrastructure for Spravato as a proxy for the potential launch environment for MindMed.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
25
The slide uses a structured table to map clinical workflow to billing codes.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
26
MindMed | Investor Presentation Deck | 28 slidesMindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
27
The slide outlines two parallel studies (Voyage and Panorama) with specific participant counts and dosing regimens.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
28
The slide uses a structured list format to map specific clinical trial risks to mitigation strategies.MindMed | Investor Presentation Deck | 28 slides · MindMed
Pitch deck Investor relations 1 hit
01
Slide 1
Nextdoor | Investor Presentation Deck | 36 slidesNextdoor | Investor Presentation Deck | 36 slides · Nextdoor
Pitch deck Investor relations 1 hit
02
Nextdoor | Investor Presentation Deck | 36 slidesNextdoor | Investor Presentation Deck | 36 slides · Nextdoor
Pitch deck Investor relations 1 hit